Last Updated on April 22, 2026 When normal soreness and real warning signs are not the same thing See which post-injection symptoms usually settle quickly and which ones deserve prompt follow-up
Hand, feet, and ankle swelling
When administered, Semaglutide activates GLP-1 receptors in the pancreas

Potential benefits of using GLP-1 receptor agonists after gastric sleeve surgery include: Enhanced weight loss : Observational studies suggest post-bariatric patients using GLP-1 receptor agonists may achieve additional weight reduction, typically around 510% of body weight, though individual responses vary considerably Improved glycaemic control : Particularly beneficial for patients with type 2 diabetes or prediabetes, as GLP-1 agonists enhance insulin secretion and reduce blood glucose levels Reduced appetite : These medications can help patients who struggle with persistent hunger despite surgical intervention Cardiovascular benefits : Semaglutide has demonstrated cardiovascular risk reduction in people with established cardiovascular disease, which may benefit eligible post-bariatric patients with this specific risk profile Maintenance of weight loss : May help prevent weight regain during the critical maintenance phase Potential risks and considerations include: Gastrointestinal side effects : Nausea, vomiting, diarrhoea, and constipation are common, particularly during dose escalation

This is a significant savings over purchasing the 100 units by vial because this treatment is different than Botox injections used to create a cosmetic result, and therefore Botox purchased at this rate is only to be used for this treatment